Ultrasound could spot deadly lung disease in scleroderma patients early
NCT ID NCT04725786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a painless, non-radiation ultrasound of the chest can find early signs of lung scarring in people with scleroderma. Thirty patients without known lung disease on CT scans underwent thoracic ultrasound. The goal was to see how often ultrasound detects hidden lung problems, potentially offering a cheaper and easier screening tool than current methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- thoracic ultrasound
- What this could lead to
- If successful, this could provide a non-invasive, low-cost way to catch lung disease early in scleroderma patients, improving treatment timing.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply broadly. Ultrasound might miss some cases or be less accurate than standard CT scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU Tours
Tours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune clues in the blood may foretell heart trouble
- Blood particles may reveal hidden clues to scleroderma complications
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Finger injections aim to loosen stiff hands in scleroderma
- Continued anifrolumab treatment studied for lupus and related diseases
- Blood thinner may stop autoimmune disease before it starts